Ohcanbohtosat - Robert A. Wolff
- Čájehuvvo 1 - 20 / 117
- Sirdás čuovvovaš siidui
-
1
-
2
-
3
-
4
Identification of novel therapeutic targets in the PI3K/AKT/mTOR pathway in hepatocellular carcinoma using targeted next generation sequencing Dahkki Filip Janků, Ahmed O. Kaseb, Apostolia M. Tsimberidou, Robert A. Wolff, Razelle Kurzrock
Almmustuhtton 2014Artigo -
5
-
6
-
7
-
8
-
9
Association Between Hepatitis B Virus and Pancreatic Cancer Dahkki Manal M. Hassan, Donghui Li, Adel S. El‐Deeb, Robert A. Wolff, Melissa L. Bondy, Marta Davila, James L. Abbruzzese
Almmustuhtton 2008Artigo -
10
XRCC2 and XRCC3 Gene Polymorphismand Risk of Pancreatic Cancer Dahkki Li Jiao, Manal M. Hassan, Melissa L. Bondy, Robert A. Wolff, Douglas B. Evans, James L. Abbruzzese, Donghui Li
Almmustuhtton 2007Artigo -
11
-
12
Fluorouracil, Doxorubicin, and Streptozocin in the Treatment of Patients With Locally Advanced and Metastatic Pancreatic Endocrine Carcinomas Dahkki Maria A. Kouvaraki, Jaffer A. Ajani, Paulo M. Hoff, Robert A. Wolff, Douglas B. Evans, Richard D. Lozano, James C. Yao
Almmustuhtton 2004Artigo -
13
A phase II study of UFT with leucovorin administered as a twice daily schedule in the treatment of patients with metastatic colorectal cancer Dahkki Paulo M. Hoff, Scott Kopetz, Melanie B. Thomas, Adrian Langleben, David Rinaldi, Lowell Anthony, Robert A. Wolff, Yvonne Lassere, James L. Abbruzzese
Almmustuhtton 2008Artigo -
14
Phase II Study of Capecitabine and Oxaliplatin for Advanced Adenocarcinoma of the Small Bowel and Ampulla of Vater Dahkki Michael J. Overman, Gauri R. Varadhachary, Scott Kopetz, Rosni Adinin, E. Lin, Jeffrey S. Morris, Cathy Eng, James L. Abbruzzese, Robert A. Wolff
Almmustuhtton 2009Artigo -
15
Phase II Study of Bevacizumab With Concurrent Capecitabine and Radiation Followed by Maintenance Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer: Radiation Thera... Dahkki Christopher H. Crane, Kathryn Winter, William F. Regine, Howard Safran, Tyvin A. Rich, Walter J. Curran, Robert A. Wolff, Christopher G. Willett
Almmustuhtton 2009Artigo -
16
Significant Effect of Homologous Recombination DNA Repair Gene Polymorphisms on Pancreatic Cancer Survival Dahkki Donghui Li, Hui Liu, Li Jiao, David Chang, Garth Beinart, Robert A. Wolff, Douglas B. Evans, Manal M. Hassan, James L. Abbruzzese
Almmustuhtton 2006Artigo -
17
Cetuximab, a Monoclonal Antibody Targeting the Epidermal Growth Factor Receptor, in Combination With Gemcitabine for Advanced Pancreatic Cancer: A Multicenter Phase II Trial Dahkki Henry Q. Xiong, Arthur Rosenberg, Albert F. LoBuglio, William Schmidt, Robert A. Wolff, John C. Deutsch, Michael N. Needle, James L. Abbruzzese
Almmustuhtton 2004Artigo -
18
Randomized, phase I/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic adenocarcinoma Dahkki Reham Abdel‐Wahab, Gauri R. Varadhachary, Priya Bhosale, Xuemei Wang, David R. Fogelman, Rachna T. Shroff, Michael J. Overman, Robert A. Wolff, Milind Javle
Almmustuhtton 2018Artigo -
19
Chemotherapy with 5‐fluorouracil and a platinum compound improves outcomes in metastatic small bowel adenocarcinoma Dahkki Michael J. Overman, Scott Kopetz, Sijin Wen, Paulo M. Hoff, David R. Fogelman, Jeffrey S. Morris, James L. Abbruzzese, Jaffer A. Ajani, Robert A. Wolff
Almmustuhtton 2008Artigo -
20
Ohcanreaiddut:
Laktáseaddji fáttát
Medicine
Internal medicine
Cancer
Oncology
Pancreatic cancer
Adenocarcinoma
Gastroenterology
Biology
Colorectal cancer
Chemotherapy
Surgery
Breast cancer
Cancer research
Gene
Pancreas
Genetics
Gemcitabine
Neoadjuvant therapy
Confidence interval
Radiation therapy
KRAS
Paleontology
Clinical trial
Radiology
Stage (stratigraphy)
Capecitabine
Environmental health
Multivariate analysis
Pancreatic ductal adenocarcinoma
Pathology